Among the soluble factors, a potent regulator of the TME is TGFβ, secreted by MM cells, bone marrow stromal cells (BMSCs), osteoblasts and Tregs [7], which hinders at various levels the anti-myeloma activity of cytotoxic lymphocytes. The gene discussed is TGFB1; the disease is Miyoshi myopathy.